245 related articles for article (PubMed ID: 12571807)
1. Pemetrexed safety and dosing strategy.
Niyikiza C; Hanauske AR; Rusthoven JJ; Calvert AH; Allen R; Paoletti P; Bunn PA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):24-9. PubMed ID: 12571807
[TBL] [Abstract][Full Text] [Related]
2. Biochemical pharmacology of pemetrexed.
Calvert AH
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):13-7. PubMed ID: 15655931
[TBL] [Abstract][Full Text] [Related]
3. The role of Pemetrexed (Alimta , LY231514) in lung cancer therapy.
Molina JR; Adjei AA
Clin Lung Cancer; 2003 Jul; 5(1):21-7. PubMed ID: 14596699
[TBL] [Abstract][Full Text] [Related]
4. Pemetrexed (ALIMTA), a novel multitargeted antineoplastic agent.
Adjei AA
Clin Cancer Res; 2004 Jun; 10(12 Pt 2):4276s-4280s. PubMed ID: 15217974
[TBL] [Abstract][Full Text] [Related]
5. Folate status and the safety profile of antifolates.
Calvert H
Semin Oncol; 2002 Apr; 29(2 Suppl 5):3-7. PubMed ID: 12023786
[TBL] [Abstract][Full Text] [Related]
6. Preclinical and clinical studies with combinations of pemetrexed and gemcitabine.
Adjei AA
Semin Oncol; 2002 Dec; 29(6 Suppl 18):30-4. PubMed ID: 12571808
[TBL] [Abstract][Full Text] [Related]
7. Molecular, biochemical, and cellular pharmacology of pemetrexed.
Goldman ID; Zhao R
Semin Oncol; 2002 Dec; 29(6 Suppl 18):3-17. PubMed ID: 12571805
[TBL] [Abstract][Full Text] [Related]
8. Pemetrexed in pancreatic cancer.
Kindler HL
Semin Oncol; 2002 Dec; 29(6 Suppl 18):49-53. PubMed ID: 12571811
[TBL] [Abstract][Full Text] [Related]
9. Antifolates in clinical development.
Takimoto CH
Semin Oncol; 1997 Oct; 24(5 Suppl 18):S18-40-S18-51. PubMed ID: 9420020
[TBL] [Abstract][Full Text] [Related]
10. Homocysteine and methylmalonic acid: markers to predict and avoid toxicity from pemetrexed therapy.
Niyikiza C; Baker SD; Seitz DE; Walling JM; Nelson K; Rusthoven JJ; Stabler SP; Paoletti P; Calvert AH; Allen RH
Mol Cancer Ther; 2002 May; 1(7):545-52. PubMed ID: 12479273
[TBL] [Abstract][Full Text] [Related]
11. Pemetrexed pharmacokinetics and pharmacodynamics in a phase I/II study of doublet chemotherapy with vinorelbine: implications for further optimisation of pemetrexed schedules.
Li KM; Rivory LP; Clarke SJ
Br J Cancer; 2007 Oct; 97(8):1071-6. PubMed ID: 17912246
[TBL] [Abstract][Full Text] [Related]
12. A semimechanistic-physiologic population pharmacokinetic/pharmacodynamic model for neutropenia following pemetrexed therapy.
Latz JE; Karlsson MO; Rusthoven JJ; Ghosh A; Johnson RD
Cancer Chemother Pharmacol; 2006 Apr; 57(4):412-26. PubMed ID: 16322990
[TBL] [Abstract][Full Text] [Related]
13. Pemetrexed: a multitargeted antifolate (ALIMTA, LY-231514).
Jones RJ; Twelves CJ
Expert Rev Anticancer Ther; 2002 Feb; 2(1):13-22. PubMed ID: 12113062
[TBL] [Abstract][Full Text] [Related]
14. Pemetrexed (Alimta): a novel multitargeted antifolate agent.
Adjei AA
Expert Rev Anticancer Ther; 2003 Apr; 3(2):145-56. PubMed ID: 12722874
[TBL] [Abstract][Full Text] [Related]
15. Overview of phase I/II pemetrexed studies.
Hanauske AR; Dittrich C; Otero J
Oncology (Williston Park); 2004 Nov; 18(13 Suppl 8):18-25. PubMed ID: 15655932
[TBL] [Abstract][Full Text] [Related]
16. Pharmacology and mechanism of action of pemetrexed.
Adjei AA
Clin Lung Cancer; 2004 Apr; 5 Suppl 2():S51-5. PubMed ID: 15117425
[TBL] [Abstract][Full Text] [Related]
17. Pemetrexed in bladder, head and neck, and cervical cancers.
Paz-Ares L; Ciruelos E; García-Carbonero R; Castellano D; Lopez-Martín A; Cortés-Funes H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):69-75. PubMed ID: 12571815
[TBL] [Abstract][Full Text] [Related]
18. Phase I trials of pemetrexed.
Fossella FV; Gatzemeier U
Semin Oncol; 2002 Apr; 29(2 Suppl 5):8-16. PubMed ID: 12023787
[TBL] [Abstract][Full Text] [Related]
19. Pemetrexed (Alimta): a promising new agent for the treatment of breast cancer.
Calvert H
Semin Oncol; 2003 Apr; 30(2 Suppl 3):2-5. PubMed ID: 12722017
[TBL] [Abstract][Full Text] [Related]
20. The role of pemetrexed in the treatment of colorectal cancer.
Hochster H
Semin Oncol; 2002 Dec; 29(6 Suppl 18):54-6. PubMed ID: 12571812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
